Review



ketamine  (Tocris)


Bioz Verified Symbol Tocris is a verified supplier
Bioz Manufacturer Symbol Tocris manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 93

    Structured Review

    Tocris ketamine
    ( a ). Schematic illustrating viral transduction strategy and two-photon Ca 2+ imaging of VTA DA neurons in acute brain slices. ( b ). Example 2PLSM image of VTA DA neurons expressing GCaMP6f. Scale bar, 20 µm. ( c ). Spontaneous Ca 2+ oscillations in one neuron with and without <t>ketamine</t> bath application (50 µM). <t>Black,</t> <t>ACSF;</t> blue, with ketamine. ( d ). Power spectral density of Ca 2+ transients for the neuron in ( c ). ( e ). Left, quantification of max power with and without ketamine treatment (n = 410 neurons). Right, quantification of frequency at max power. Paired two-tailed t test, ACSF vs KET, Max power, p = 0.8865, Frequency at max power, p = 0.3779. ( f ). Left, histogram showing the distribution of changes in max power with ketamine application. Right, same but for frequency at max power. n = 410 neurons. ( g ). Schematic illustrating viral transduction strategy and electrophysiological recording of VTA DA neurons in acute brain slices. ( h ). Spontaneous action potentials recorded in one neuron with and without ketamine bath application (50 µM). Black, ACSF; blue, with ketamine. ( i ). Quantification of neuronal firing rate with and without ketamine treatment (n = 9 neurons from three animals). Paired two-tailed t test, ACSF vs KET, p = 0.2561. ( j ). Spontaneous EPSCs recorded in one neuron with and without ketamine bath application (50 µM). Black, ACSF; blue, with ketamine. Holding membrane potential at –70 mV, 10 µM Gabazine in ASCF for both conditions. ( k ). Left, cumulative frequency distribution of sEPSCs amplitudes. Right, quantification of sEPSC amplitude in recorded neurons. Paired two-tailed t test, ACSF vs KET, p = 0.1958. n = 17 neurons from three animals. ( l ). Same as ( k ), but for sEPSCs inter-event intervals (IEI). Paired two-tailed t test, ACSF vs KET, p = 0.8413. ( m ). Spontaneous IPSCs recorded in one neuron with and without ketamine bath application (50 µM). Black, ACSF; blue, with ketamine. Holding membrane potential at –70 mV with high chloride internal solution, 10 µM CNQX in ASCF for both conditions. ( n ). Left, cumulative frequency distribution of sIPSCs amplitudes. Right, quantification of sIPSC amplitude in recorded neurons. Paired two-tailed t test, ACSF vs KET, p = 0.9164. n = 12 neurons from two animals. ( o ). Same as ( n ), but for sIPSCs inter-event intervals (IEI). Paired two-tailed t test, ACSF vs KET, p = 0.5675. Figure 4—source data 1. Numerical data for the graphs in .
    Ketamine, supplied by Tocris, used in various techniques. Bioz Stars score: 93/100, based on 110 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/sigma+plot+12%2E5+computer+software/Ketamine+hydrochloride/pmc08211450-343-31-49
    Average 93 stars, based on 110 article reviews
    ketamine - by Bioz Stars, 2026-08
    93/100 stars

    Images

    1) Product Images from "Attenuated dopamine signaling after aversive learning is restored by ketamine to rescue escape actions"

    Article Title: Attenuated dopamine signaling after aversive learning is restored by ketamine to rescue escape actions

    Journal: eLife

    doi: 10.7554/eLife.64041

    ( a ). Schematic illustrating viral transduction strategy and two-photon Ca 2+ imaging of VTA DA neurons in acute brain slices. ( b ). Example 2PLSM image of VTA DA neurons expressing GCaMP6f. Scale bar, 20 µm. ( c ). Spontaneous Ca 2+ oscillations in one neuron with and without ketamine bath application (50 µM). Black, ACSF; blue, with ketamine. ( d ). Power spectral density of Ca 2+ transients for the neuron in ( c ). ( e ). Left, quantification of max power with and without ketamine treatment (n = 410 neurons). Right, quantification of frequency at max power. Paired two-tailed t test, ACSF vs KET, Max power, p = 0.8865, Frequency at max power, p = 0.3779. ( f ). Left, histogram showing the distribution of changes in max power with ketamine application. Right, same but for frequency at max power. n = 410 neurons. ( g ). Schematic illustrating viral transduction strategy and electrophysiological recording of VTA DA neurons in acute brain slices. ( h ). Spontaneous action potentials recorded in one neuron with and without ketamine bath application (50 µM). Black, ACSF; blue, with ketamine. ( i ). Quantification of neuronal firing rate with and without ketamine treatment (n = 9 neurons from three animals). Paired two-tailed t test, ACSF vs KET, p = 0.2561. ( j ). Spontaneous EPSCs recorded in one neuron with and without ketamine bath application (50 µM). Black, ACSF; blue, with ketamine. Holding membrane potential at –70 mV, 10 µM Gabazine in ASCF for both conditions. ( k ). Left, cumulative frequency distribution of sEPSCs amplitudes. Right, quantification of sEPSC amplitude in recorded neurons. Paired two-tailed t test, ACSF vs KET, p = 0.1958. n = 17 neurons from three animals. ( l ). Same as ( k ), but for sEPSCs inter-event intervals (IEI). Paired two-tailed t test, ACSF vs KET, p = 0.8413. ( m ). Spontaneous IPSCs recorded in one neuron with and without ketamine bath application (50 µM). Black, ACSF; blue, with ketamine. Holding membrane potential at –70 mV with high chloride internal solution, 10 µM CNQX in ASCF for both conditions. ( n ). Left, cumulative frequency distribution of sIPSCs amplitudes. Right, quantification of sIPSC amplitude in recorded neurons. Paired two-tailed t test, ACSF vs KET, p = 0.9164. n = 12 neurons from two animals. ( o ). Same as ( n ), but for sIPSCs inter-event intervals (IEI). Paired two-tailed t test, ACSF vs KET, p = 0.5675. Figure 4—source data 1. Numerical data for the graphs in .
    Figure Legend Snippet: ( a ). Schematic illustrating viral transduction strategy and two-photon Ca 2+ imaging of VTA DA neurons in acute brain slices. ( b ). Example 2PLSM image of VTA DA neurons expressing GCaMP6f. Scale bar, 20 µm. ( c ). Spontaneous Ca 2+ oscillations in one neuron with and without ketamine bath application (50 µM). Black, ACSF; blue, with ketamine. ( d ). Power spectral density of Ca 2+ transients for the neuron in ( c ). ( e ). Left, quantification of max power with and without ketamine treatment (n = 410 neurons). Right, quantification of frequency at max power. Paired two-tailed t test, ACSF vs KET, Max power, p = 0.8865, Frequency at max power, p = 0.3779. ( f ). Left, histogram showing the distribution of changes in max power with ketamine application. Right, same but for frequency at max power. n = 410 neurons. ( g ). Schematic illustrating viral transduction strategy and electrophysiological recording of VTA DA neurons in acute brain slices. ( h ). Spontaneous action potentials recorded in one neuron with and without ketamine bath application (50 µM). Black, ACSF; blue, with ketamine. ( i ). Quantification of neuronal firing rate with and without ketamine treatment (n = 9 neurons from three animals). Paired two-tailed t test, ACSF vs KET, p = 0.2561. ( j ). Spontaneous EPSCs recorded in one neuron with and without ketamine bath application (50 µM). Black, ACSF; blue, with ketamine. Holding membrane potential at –70 mV, 10 µM Gabazine in ASCF for both conditions. ( k ). Left, cumulative frequency distribution of sEPSCs amplitudes. Right, quantification of sEPSC amplitude in recorded neurons. Paired two-tailed t test, ACSF vs KET, p = 0.1958. n = 17 neurons from three animals. ( l ). Same as ( k ), but for sEPSCs inter-event intervals (IEI). Paired two-tailed t test, ACSF vs KET, p = 0.8413. ( m ). Spontaneous IPSCs recorded in one neuron with and without ketamine bath application (50 µM). Black, ACSF; blue, with ketamine. Holding membrane potential at –70 mV with high chloride internal solution, 10 µM CNQX in ASCF for both conditions. ( n ). Left, cumulative frequency distribution of sIPSCs amplitudes. Right, quantification of sIPSC amplitude in recorded neurons. Paired two-tailed t test, ACSF vs KET, p = 0.9164. n = 12 neurons from two animals. ( o ). Same as ( n ), but for sIPSCs inter-event intervals (IEI). Paired two-tailed t test, ACSF vs KET, p = 0.5675. Figure 4—source data 1. Numerical data for the graphs in .

    Techniques Used: Transduction, Imaging, Expressing, Two Tailed Test, Membrane

    ( a ). Top, schematic for selected glutamatergic input regions to VTA. Bottom, experimental timeline. ( b ). Summary data showing the percentage of failures after local infusion of ketamine or ACSF in mPFC, and ketamine in PAG, PPTg, and VTA. Two-way ANOVA, Sidak’s multiple comparison test, LH vs LH+ KET, mPFC, p< 0.0001, PAG, p = 0.4965, PPTg, p = 0.9998, VTA, p = 0.9986. LH vs LH+ ACSF (mPFC), p = 0.9993. ( c ). Schematic for viral transduction and VTA photometry recording of Ca 2+ transients with local ketamine delivery in mPFC. ( d ). Left, average Ca 2+ transients (mean ± SEM) in response to foot shocks at the start of induction, at the end of induction, and following local ketamine infusion. Traces are aligned to shock start time (20 trials/animal, 6 animals). Right, quantification of peak Ca 2+ transient amplitude during and after foot shock stimuli across conditions. Both positive and negative values are quantified. n = 6 animals, repeated measures one-way ANOVA, Holm-Sidak’s multiple comparison test, Peak: During shock, F (1.948, 9.739) = 5.547, p = 0.0252, Induction start vs Induction end p = 0.0433, Induction end vs LH + KET, p = 0.0823. After shock, F (1.468, 7.341) = 10.05, p = 0.0105, Induction start vs Induction end, p = 0.0462, Induction end vs LH + KET, p = 0.0147. *p < 0.05, *** p < 0.001, **** p < 0.0001. Error bars reflect SEM. Figure 5—source data 1. Numerical data for the graphs in .
    Figure Legend Snippet: ( a ). Top, schematic for selected glutamatergic input regions to VTA. Bottom, experimental timeline. ( b ). Summary data showing the percentage of failures after local infusion of ketamine or ACSF in mPFC, and ketamine in PAG, PPTg, and VTA. Two-way ANOVA, Sidak’s multiple comparison test, LH vs LH+ KET, mPFC, p< 0.0001, PAG, p = 0.4965, PPTg, p = 0.9998, VTA, p = 0.9986. LH vs LH+ ACSF (mPFC), p = 0.9993. ( c ). Schematic for viral transduction and VTA photometry recording of Ca 2+ transients with local ketamine delivery in mPFC. ( d ). Left, average Ca 2+ transients (mean ± SEM) in response to foot shocks at the start of induction, at the end of induction, and following local ketamine infusion. Traces are aligned to shock start time (20 trials/animal, 6 animals). Right, quantification of peak Ca 2+ transient amplitude during and after foot shock stimuli across conditions. Both positive and negative values are quantified. n = 6 animals, repeated measures one-way ANOVA, Holm-Sidak’s multiple comparison test, Peak: During shock, F (1.948, 9.739) = 5.547, p = 0.0252, Induction start vs Induction end p = 0.0433, Induction end vs LH + KET, p = 0.0823. After shock, F (1.468, 7.341) = 10.05, p = 0.0105, Induction start vs Induction end, p = 0.0462, Induction end vs LH + KET, p = 0.0147. *p < 0.05, *** p < 0.001, **** p < 0.0001. Error bars reflect SEM. Figure 5—source data 1. Numerical data for the graphs in .

    Techniques Used: Comparison, Transduction


    Figure Legend Snippet:

    Techniques Used: Recombinant, Plasmid Preparation, RNAscope, Fluorescence, Multiplex Assay, Software



    Similar Products

    90
    SYSTAT sigma plot 12.5 computer software
    Sigma Plot 12.5 Computer Software, supplied by SYSTAT, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/sigma+plot+12%2E5+computer+software/sigma+plot+11+0/pmc09029359-107-6-10
    Average 90 stars, based on 1 article reviews
    sigma plot 12.5 computer software - by Bioz Stars, 2026-08
    90/100 stars
      Buy from Supplier

    Image Search Results